A recent article in Harvard Business Review features MSK’s new InSight Care program. It is written by three members of the MSK team working on the program, Dr. Robert Daly, Abigail Baldwin-Medsker, and Wendy Perchick.
The goal of InSight Care is to predict each chemotherapy patient’s risk of needing care between treatments through an analytical model based on previous patient observations, a patient-reported symptom survey, and a team of nurses and advanced practice professionals who use the platform to monitor and communicate with patients remotely.
Of the 106 patients in the program’s pilot, 14 (13%) required acute care at MSK, compared to 32% of similar patients not participating in the program. Patients report that they appreciate the quick, 24/7 care InSight Care provides them without their having to leave home. The authors plan to expand the pilot and continue to refine the tool.